Hemispherx Biopharma

Hemispherx Biopharma, Inc. has devoted nearly three decades to exploring, understanding, and mastering the mechanism of RNA technology. The Company's longevity as a biomedical research and drug development institution, coupled with its record of tremendous enduring scientific achievement is evidence of Hemispherx’s long-term commitment to this promising new class of drugs and to bring new therapeutic choices to the global community.



Using nucleic acid technologies to develop therapeutic products for the treatment of viral disease and certain cancers, the company has pioneered a new class of specifically-configured ribonucleic acid (RNA) which targets the treatment of Chronic Fatigue Syndrome (CFS), HIV associated disorders, chronic hepatitis B & C infection and cancers which include kidney cancer and metastatic malignant melanoma. Hemispherx with its predecessor, HEM Pharmaceuticals has nearly 30 years of RNA technology and is believed to be the only biotechnology company using nucleic acid drug methodology targeting the body's natural anti-viral defense system.

Contact Details: One Penn Center 1617 JFK Blvd., 6th Floor Philadelphia PA 19103 United States of America Tel: (215) 988-0080 Fax: (215) 988-1739 Email: info@hemispherx.net WWW: www.hemispherx.net/

Loading...

Recent Publications by Hemispherx Biopharma:
Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI:polyC12U in the treatment of HIV infection. In this multicenter, randomized, double-blind study the activity of...	29th March, 2000	Hemispherx Biopharma Incorporated, Philadelphia, Pennsylvania 19103, USA.	Eur J Clin Microbiol Infect Dis. 1996 Jul;15(7):580-7.

BioNews Results for Hemispherx Biopharma:
Hemispherx to Present Data At 'Second World Conference On Magic Bullets (Erlich II)'	Yahoo!:  Sep 30 2008 1:35PM Matching: hemispherx biopharma
Hemispherx to Present Data At 'Second World Conference On Magic Bullets (Erlich II)'	Therapeutics Daily:  Sep 30 2008 2:33PM Matching: hemispherx biopharma
Analyst Reports for Inmet Mining Corporation, Addax Petroleum Corporation, Hemispherx Biopharma Inc. and India	Quote.com India:  Sep 26 2008 10:06PM Matching: hemispherx biopharma
Analyst Reports for Inmet Mining Corporation, Addax Petroleum Corporation, Hemispherx Biopharma Inc. and India	Street Insider:  Sep 26 2008 4:23PM Matching: hemispherx biopharma
Analyst Reports for Inmet Mining Corporation, Addax Petroleum Corporation, Hemispherx Biopharma Inc. and India	Yahoo! Canada:  Sep 26 2008 4:14PM Matching: hemispherx biopharma
Promote your company here: BioNewsCast - Press Release Distribution	→View more Hemispherx Biopharma news.

Hemispherx Biopharma Patents:
US Patent No.	Title
5958718	Diagnosis and treatment of neuro-cognitive disorders associated with systemic immunological malfunction
5763417	Protection from septic shock subsequent to injury by dsRNAs
5683986	Elaboration of host defense mediators into biological fluids by systemic dsRNA treatment
5593973	Treatment of viral hepatitis with mismatched dsRNA

Hemispherx Biopharma (HEB) Financial information Links from Barchart
HEB Quote from from Barchart.com
HEB Chart from from Barchart.com
HEB Profile from from Barchart.com
HEB Opinion from from Barchart.com
→View more Hemispherx Biopharma finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 231 times since April 2007, the link to the organisation's website has been followed 41 times

Recent Search Terms used to find this page: biopharma neuro | hemispherx | hemispherx biopharma | .

Search for more companies in Philadelphia

Search for more companies in PA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Hemispherx Biopharma